The Chemours Company $CC Shares Bought by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. has increased its stake in The Chemours Company by 610.5%, acquiring a total of 66,180 shares valued at $896,000 by the end of the first quarter.
• Chemours reported earnings per share of $0.58 for the last quarter, surpassing estimates by $0.12, with total revenue of $1.62 billion compared to forecasts of $1.57 billion.
• The company plans to pay a quarterly dividend of $0.0875, resulting in an annualized dividend yield of 2.3%, despite a negative dividend payout ratio of -12.50%.

Russell Investments Group Ltd. increased its position in shares of The Chemours Company (NYSE:CC - Free Report) by 610.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 66,180 shares of the specialty chemicals company's stock after purchasing an additional 56,866 shares during the period. Russell Investments Group Ltd.'s holdings in Chemours were worth $896,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SG Americas Securities LLC purchased a new position in Chemours during the first quarter worth about $822,000. Principal Financial Group Inc. boosted its stake in Chemours by 116.3% during the first quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock worth $10,041,000 after buying an additional 399,097 shares during the period. Janney Montgomery Scott LLC boosted its stake in Chemours by 22.4% during the first quarter. Janney Montgomery Scott LLC now owns 31,886 shares of the specialty chemicals company's stock worth $431,000 after buying an additional 5,843 shares during the period. GAMMA Investing LLC boosted its stake in Chemours by 1,115.2% during the first quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock worth $252,000 after buying an additional 17,085 shares during the period. Finally, Bessemer Group Inc. boosted its stake in Chemours by 8.7% during the first quarter. Bessemer Group Inc. now owns 38,554 shares of the specialty chemicals company's stock worth $522,000 after buying an additional 3,081 shares during the period. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Stock Up 0.7%

NYSE:CC traded up $0.11 during mid-day trading on Thursday, hitting $15.09. The stock had a trading volume of 2,921,313 shares, compared to its average volume of 3,469,233. The stock has a 50-day simple moving average of $13.65 and a two-hundred day simple moving average of $12.79. The company has a market capitalization of $2.26 billion, a PE ratio of -5.39 and a beta of 1.61. The Chemours Company has a twelve month low of $9.13 and a twelve month high of $22.38. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16.

Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.12. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The firm had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.57 billion. During the same quarter last year, the company earned $0.38 earnings per share. The firm's revenue was up 5.0% compared to the same quarter last year. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts anticipate that The Chemours Company will post 2.03 EPS for the current year.

Chemours Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a yield of 2.3%. Chemours's dividend payout ratio (DPR) is presently -12.50%.

Insiders Place Their Bets

In related news, CEO Denise Dignam acquired 4,068 shares of the business's stock in a transaction on Friday, August 8th. The shares were bought at an average price of $12.06 per share, with a total value of $49,060.08. Following the completion of the acquisition, the chief executive officer owned 191,546 shares in the company, valued at $2,310,044.76. This trade represents a 2.17% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.47% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CC shares. UBS Group lowered their target price on shares of Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Mizuho raised their price objective on shares of Chemours from $13.00 to $16.00 and gave the company an "outperform" rating in a research note on Tuesday, July 15th. Zacks Research raised shares of Chemours from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 27th. Royal Bank Of Canada raised their price objective on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research note on Thursday, July 3rd. Finally, Morgan Stanley lowered their price objective on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research note on Monday, May 12th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Chemours has a consensus rating of "Moderate Buy" and a consensus target price of $17.38.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.